Please login to the form below

Destiny Pharma

This page shows the latest Destiny Pharma news and features for those working in and with pharma, biotech and healthcare.

Ex-Pfizer research head Dr David Roblin joins Destiny Pharma

The former head of research at Pfizer's European operations will be medical director at Destiny. ... Anti-microbial drug development company Destiny Pharma has appointed ex-Pfizer research head Dr David Roblin as medical director.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Choosing destiny

Step 1: From history to destiny. Although, in theory, firms can choose between any of the 26 business models shown in figure 1, in practice they are constrained by their history. ... to, for example, Sun Pharma and vice-versa.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Pharma industry appointments

Nick Rodgers joins Destiny Pharma. Clinical stage biotech Destiny Pharma has announced that Nick Rodgers will join the company as its independent non-executive director, effective immediately. ... Sir Nigel Rudd, chairman of Destiny Pharma, said:
Ergomed appoints CEO of PrimeVigilance

Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition
Destiny Pharma appoints new CEO

Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate. ... Nigel Rudd, non-executive chairman of Destiny Pharma, said: “I am delighted to welcome Neil Clark as chief

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Healthcare Communications Account Directors x 2: Salary TBC

Editorial Manager - MedComms: DOE

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Account Director: Competitive Salary Offered

Senior Account Manager: Competitive Salary Offered

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Manager / Account Director: Competative

Associate Director: £75, 000-90, 000

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Executive/ Senior Account Executive: competitive Salary Offfered

Principal Health Economist - North-West: Negotiable

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Editorial Assistant – Greater Manchester: DOE

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Business Director: Competitive Salary Offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Medical (Scientific) Director: £120, 000 benefits

Subscribe to our email news alerts

PMHub

Add my company

CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today: Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham: Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...